Ontogeny of pituitary adenylate cyclase activating polypeptide and its receptor mRNA in the mouse brain

被引:46
|
作者
Shuto, Y
Uchida, D
Onda, H
Arimura, A
机构
[1] TULANE UNIV,HEBERT CTR,US JAPAN BIOMED RES LABS,BELLE CHASSE,LA 70037
[2] TULANE UNIV,SCH MED,DEPT MED,NEW ORLEANS,LA 70112
[3] TULANE UNIV,SCH MED,DEPT PHYSIOL,NEW ORLEANS,LA 70112
[4] TULANE UNIV,SCH MED,DEPT ANAT,NEW ORLEANS,LA 70112
[5] TAKEDA CHEM IND LTD,DISCOVERY RES LABS 1,TSUKUBA,IBARAKI 30042,JAPAN
关键词
pituitary adenylate cyclase-activating polypeptide (PACAP); type I PACAP receptor; gene expression; development;
D O I
10.1016/S0167-0115(96)00116-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide which was first isolated from ovine hypothalamic tissue by screening for pituitary adenylate cyclase stimulating activity. Our previous data showed that radioimmunoassayable PACAP and PACAP-binding sites were detected in the whole rat brain as early as embryonic day 14 (E14). In order to understand more precisely the developmental pattern of the synthesis of PACAP and its receptors in the brain, we studied the expression of PACAP and its receptor genes in the prenatal and postnatal mouse brain using RNase protection assay. The mRNAs for both PACAP and its receptor were detected as early as 9.5 days of gestation (E9.5) in the whole head of mouse embryos. The levels of PACAP mRNA in the brain increased during the prenatal period peaking at postnatal day 0 (P0). On the other hand, the levels of PACAP receptor mRNA gradually increased after E9.5. The levels sharply increased at P6 (479.0 +/- 82.5% of P0 levels), and then fell to the P3 levels at P10. These data together with our previous study on the ontogeny of PACAP immunoreactivity and its binding sites in the rat brain support the view that PACAP plays an important regulatory role in the development of brain.
引用
收藏
页码:79 / 83
页数:5
相关论文
共 50 条
  • [41] CONCENTRATIONS OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) IN HUMAN BRAIN NUCLEI
    PALKOVITS, M
    SOMOGYVARIVIGH, A
    ARIMURA, A
    BRAIN RESEARCH, 1995, 699 (01) : 116 - 120
  • [42] Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury
    Farkas, O
    Tamás, A
    Zsombok, A
    Reglödi, D
    Pál, J
    Büki, A
    Lengvári, I
    Povlishock, JT
    Dóczi, T
    REGULATORY PEPTIDES, 2004, 123 (1-3) : 69 - 75
  • [43] Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide
    Ngoc-Duc Doan
    Chatenet, David
    Letourneau, Myriam
    Vaudry, Hubert
    Vaudry, David
    Fournier, Alain
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2012, 1823 (04): : 940 - 949
  • [44] Pituitary adenylate cyclase activating polypeptide:: A potential neuroprotective peptide
    Somogyvári-Vigh, A
    Reglodi, D
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (23) : 2861 - 2889
  • [45] Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia
    R Hashimoto
    H Hashimoto
    N Shintani
    S Chiba
    S Hattori
    T Okada
    M Nakajima
    K Tanaka
    N Kawagishi
    K Nemoto
    T Mori
    T Ohnishi
    H Noguchi
    H Hori
    T Suzuki
    N Iwata
    N Ozaki
    T Nakabayashi
    O Saitoh
    A Kosuga
    M Tatsumi
    K Kamijima
    D R Weinberger
    H Kunugi
    A Baba
    Molecular Psychiatry, 2007, 12 : 1026 - 1032
  • [46] The pituitary adenylate cyclase activating polypeptide (PACAP):: A review.
    Mucio-Ramírez, S
    Miller-Pérez, C
    Curras-Collazo, M
    León-Olea, M
    SALUD MENTAL, 2004, 27 (02) : 55 - 69
  • [47] Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia
    Hashimoto, R.
    Hashimoto, H.
    Shintani, N.
    Chiba, S.
    Hattori, S.
    Okada, T.
    Nakajima, M.
    Tanaka, K.
    Kawagishi, N.
    Nemoto, K.
    Mori, T.
    Ohnishi, T.
    Noguchi, H.
    Hori, H.
    Suzuki, T.
    Iwata, N.
    Ozaki, N.
    Nakabayashi, T.
    Saitoh, O.
    Kosuga, A.
    Tatsumi, M.
    Kamijima, K.
    Weinberger, D. R.
    Kunugi, H.
    Baba, A.
    MOLECULAR PSYCHIATRY, 2007, 12 (11) : 1026 - 1032
  • [48] Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death
    Horvath, Gabriella
    Reglodi, Dora
    Fabian, Eszter
    Opper, Balazs
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [49] Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide
    Gonzalez, BJ
    Basille, M
    Vaudry, D
    Fournier, A
    Cazin, L
    Vaudry, H
    TRENDS IN COMPARATIVE ENDOCRINOLOGY AND NEUROBIOLOGY: FROM MOLECULAR TO INTEGRATIVE BIOLOGY, 1998, 839 : 551 - 552
  • [50] Pituitary Adenylate Cyclase-Activating Polypeptide in Learning and Memory
    Gilmartin, Marieke R.
    Ferrara, Nicole C.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15